Thomas Pointdexter Bersot, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bersot’s office at (415) 206-4615 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G26303 · Current
Licensed to practise in California · since 1974 · expires 2028-09-30 · Vanderbilt University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Medicaid work
$4,437 in 2024
Medicaid paid $4,437 for 13 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 13 | $4,437 |
| 2024 | 13 | 1 | 13 | $4,437 |
Drugs they prescribed that Part D paid
$27,856
Pharmacies billed $27,856 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 51) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
26 generic and 25 brand-name prescriptions · $27,856 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Praluent | 11 | $5,306 | $482 |
| Ezetimibe | 11 | $1,036 | $94 |
Year by year
| 2024 | 51 | 16 | 0% (0) | 49% | $27,856 |
| 2023 | 92 | 19 | 0% (0) | 41% | $30,467 |
| 2022 | 117 | 21 | 0% (0) | 19% | $22,327 |
| 2021 | 132 | 23 | 0% (0) | 17% | $21,068 |
| 2020 | 132 | 23 | 0% (0) | 25% | $29,039 |
| 2019 | 71 | 17 | 0% (0) | 24% | $28,739 |
| 2018 | 116 | 28 | 0% (0) | 21% | $38,818 |
| 2017 | 124 | 29 | 0% (0) | None | $36,001 |
| 2016 | 121 | 29 | 0% (0) | 42% | $32,111 |
| 2015 | 176 | 29 | 0% (0) | 41% | $28,335 |
| 2014 | 196 | 30 | 0% (0) | 51% | $29,165 |
| 2013 | 195 | 32 | 0% (0) | None | $24,110 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Praluent | 15 | $10,053 | $670 |
| Ezetimibe | 13 | $1,248 | $96 |
| Atorvastatin | 17 | $720 | $42 |
2022: 4 drugs
| Praluent | 13 | $7,537 | $580 |
| Ezetimibe | 24 | $2,148 | $90 |
| Fenofibrate | 15 | $1,381 | $92 |
| Atorvastatin | 26 | $423 | $16 |
2021: 6 drugs
| Praluent | 12 | $5,795 | $483 |
| Rosuvastatin | 21 | $1,819 | $87 |
| Ezetimibe | 18 | $1,039 | $58 |
| Atorvastatin | 25 | $306 | $12 |
| Fenofibrate | 12 | $96 | $8 |
| Lisinopril | 12 | $26 | $2 |
2020: 6 drugs
| Praluent | 22 | $13,354 | $607 |
| Rosuvastatin | 29 | $1,597 | $55 |
| Ezetimibe | 17 | $1,110 | $65 |
| Atorvastatin | 23 | $569 | $25 |
| Fenofibrate | 12 | $150 | $13 |
| Lisinopril | 12 | $47 | $4 |
2019: 3 drugs
| Praluent | 12 | $14,363 | $1,197 |
| Rosuvastatin | 20 | $1,697 | $85 |
| Ezetimibe | 19 | $936 | $49 |
2018: 4 drugs
| Praluent | 22 | $26,206 | $1,191 |
| Ezetimibe | 29 | $3,714 | $128 |
| Rosuvastatin | 32 | $2,530 | $79 |
| Atorvastatin | 18 | $520 | $29 |
2017: 4 drugs
| Praluent | 14 | $16,622 | $1,187 |
| Ezetimibe | 11 | $3,679 | $334 |
| Rosuvastatin | 33 | $3,058 | $93 |
| Atorvastatin | 23 | $625 | $27 |
2016: 4 drugs
| Zetia | 14 | $7,040 | $503 |
| Crestor | 13 | $6,048 | $465 |
| Rosuvastatin | 17 | $1,970 | $116 |
| Atorvastatin | 35 | $714 | $20 |
2015: 6 drugs
| Crestor | 26 | $9,458 | $364 |
| Welchol | 11 | $6,215 | $565 |
| Zetia | 18 | $5,402 | $300 |
| Fenofibrate | 27 | $1,793 | $66 |
| Atorvastatin | 46 | $858 | $19 |
| Simvastatin | 11 | $67 | $6 |
2014: 9 drugs
| Crestor | 28 | $7,010 | $250 |
| Zetia | 26 | $6,050 | $233 |
| Welchol | 13 | $5,054 | $389 |
| Vytorin | 14 | $2,717 | $194 |
| Fenofibrate | 24 | $1,750 | $73 |
| Fenofibrate | 16 | $1,705 | $107 |
| Atorvastatin | 21 | $1,084 | $52 |
| Pravastatin | 11 | $238 | $22 |
| Simvastatin | 11 | $90 | $8 |
2013: 8 drugs
| Zetia | 25 | $6,429 | $257 |
| Welchol | 12 | $3,681 | $307 |
| Crestor | 12 | $3,628 | $302 |
| Vytorin | 17 | $3,124 | $184 |
| Fenofibrate | 39 | $2,533 | $65 |
| Atorvastatin | 28 | $1,107 | $40 |
| Fenofibrate | 11 | $935 | $85 |
| Benazepril | 14 | $75 | $5 |
Money from drug and device companies
$6,604 in 2019
A payment is not proof that care is biased.
| Amarin Pharma | Vascepa | $6,604 | 13 payments
|
See all 13 published payments
| Amarin Pharma | Meals · 2019-12-11 | Vascepa | $23 |
| Amarin Pharma | Travel · 2019-11-04 | Vascepa | $24 |
| Amarin Pharma | Travel · 2019-11-04 | Vascepa | $24 |
| Amarin Pharma | Consulting · 2019-11-04 | Vascepa | $5,000 |
| Amarin Pharma | Meals · 2019-11-04 | Vascepa | $65 |
| Amarin Pharma | Meals · 2019-10-31 | Vascepa | $29 |
| Amarin Pharma | Travel · 2019-10-31 | Vascepa | $259 |
| Amarin Pharma | Meals · 2019-10-31 | Vascepa | $48 |
| Amarin Pharma | Meals · 2019-10-31 | Vascepa | $54 |
| Amarin Pharma | Travel · 2019-10-23 | Vascepa | $303 |
| Amarin Pharma | Travel · 2019-10-23 | Vascepa | $419 |
| Amarin Pharma | Travel · 2019-10-23 | Vascepa | $322 |
| Amarin Pharma | Travel · 2019-10-23 | Vascepa | $35 |
Professional record
- NPI
- 1205037629
- Licence
- CA G26303California G26303: Current · expires 2028-09-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G263030
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 1650 Owens Street, San Francisco, CA, 94158
- NPI first listed
- 2007-05-31
- NPI last updated
- 2007-07-11
This is when the NPI record was last certified, not a medical board exam.